(Updates dateline, adds AbbVie-Iambic deal) Sept 21 (Reuters) – Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate research and development, betting on new
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
New Delhi [India], September 21: Bench Mark Infotech Services Limited, an integrated IT and digital…
* Yields track oil prices lower * European yields also fall * Two-year Treasury yield…
By Jody Godoy Sept 21 (Reuters) - Paramount Skydance has settled with California and 11…
Sept 21 (Reuters) - Payments and banking solutions provider Priority Technology Holdings said on Monday…
Sept 21 (Reuters) - Shares of Warner Bros Discovery and Paramount Skydance jumped on Monday,…
Sept 21 (Reuters) - Continental Aerospace Technologies Holding Ltd: * APPROVES WITHDRAWAL OF LISTING AND…